when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Vera Therapeutics, Inc. ($VERA) · news · pharmadog

← back to Vera Therapeutics, Inc.

News mentioning $VERA

64 stories

Aug 6, 26Takeda’s narcolepsy nod opens orexin doorsbiospace

Aug 4, 26Vertex unfazed by competitive IgAN space as FDA verdict loomsbiospace

Jul 31, 26Federal government could improve infectious disease monitoring, says federal governmentstat

Jul 31, 26Syphilis spreads while researchers contend with federal constraints and a drug shortagestat

Jul 29, 26Incyte cuts early-stage cancer drug to focus on next-gen programsbiospace

Jul 21, 26Agios axes next-gen sickle cell candidate after it fails to best Novo’s assetbiospace

Jul 21, 26Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial rolefiercebiotech

Jul 20, 26Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvalsbiospace

Jul 20, 26BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’fiercebiotech

Jul 14, 26STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and morestat

Jul 13, 26STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patentsstat

Jul 13, 26STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and morestat

Jul 10, 26STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and morestat

Jul 9, 26STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and morestat

Jul 9, 26STAT+: The quest to save Grace — and clear the way for rare disease patients everywherestat

Jul 8, 26STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccinesstat

Jul 8, 26Bryan Johnson’s chronic disease is notoriously difficult to diagnosestat

Jul 8, 26Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysstat

Jul 8, 26STAT+: Europe will accelerate its review of RevMed’s drugstat

Jul 8, 26STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeuticsstat

Jul 8, 26STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

Jul 8, 26Another big premium hike on the horizonstat

Jul 8, 26Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsstat

Jul 7, 26Vera's IgAN approval kicks off competition with Otsukaendpoints

Jul 7, 26STAT+: FDA approves Vera Therapeutics kidney disease treatmentstat

Jul 7, 26STAT+: Compass says depression drug has long-lasting benefitsstat

Jul 7, 26STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and morestat

Jul 7, 26Vera Therapeutics wins FDA nod for closely watched kidney disease drugbiopharma dive

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 4, 26Otsuka showcases kidney drug data; Pfizer cuts an AI dealbiopharma dive

← prevpage 2 of 3next →